Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes

3 Sept 2020

Abstract excerpt

The World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) as a public health emergency of international concern as more than 15 million cases were reported by 24th July 2020. Angiotensin-converting enzyme 2 (ACE2) is a COVID-19 entry receptor regulating host cell infection. A recent study reported that ACE2 is expressed in cardiomyocytes. In this study, we aimed to explore if there are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32891636
DOI: 10.1016/j.yjmcc.2020.08.017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytesPMID 32891636Read ↗

MicroRNAs Bioinformatics Analyses Identifying HDAC Pathway as a Putative Target for Existing Anti‐COVID‐19 TherapeuticsSemantic proximity Read ↗

Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytesSemantic proximity Read ↗

Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patientsSemantic proximity Read ↗

Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated reviewSemantic proximity Read ↗

Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 ImmunopathologySemantic proximity Read ↗

Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main ReceptorSemantic proximity Read ↗

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19Semantic proximity Read ↗

ACE2: the molecular doorway to SARS-CoV-2Semantic proximity Read ↗

Genes Encoding ACE2, TMPRSS2 and Related Proteins Mediating SARS-CoV-2 Viral Entry are Upregulated with Age in Human CardiomyocytesSemantic proximity Read ↗

Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2Semantic proximity Read ↗

Angiotensin Converting Enzyme 2 in Coronavirus Disease (COVID-19): Evidence from Bioinformatics AnalysisSemantic proximity Read ↗

Potential role of ACE2-related microRNAs in COVID-19-associated nephropathySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.